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Abstract 
Background: Osseointegration, an approach for direct skeletal attachment of a prosthesis to an 
amputated limb, may address many of the socket-related problems associated with socket prosthesis. 
However, the safety issues and adverse events associated with osseointegration is uncertain. This 
study aimed to summarize evidence on functional and clinical outcomes, as well as adverse effects of 
osseointegration for patients with amputated limbs.  
Methods: MEDLINE, EMBASE, Web of Science, and Cochrane Library were searched to April 
2018. Eligible studies were observational, case, and qualitative studies, and randomized controlled 
trials (RCTs) conducted in patients with limb amputations, who were managed with osseointegrated 
prostheses, and had follow-up data.  
Results: Twenty-two eligible articles comprising 13 unique studies were included. No RCT was 
identified. Sample sizes ranged from 11 to 100 participants. All relevant studies reported 
improvement in functional outcomes (walking ability, prosthetic use, and mobility), satisfaction, and 
quality of life following osseointegration compared with their preoperative status or when using 
conventional socket prosthesis. Infection rates (95% confidence intervals) ranged from 1.0% (0.2-5.4) 
to 76.7% (59.1-88.2). Majority of these infections were described as low-grade soft tissue or 
superficial infections related to the skin-implant interface, which were effectively treated with 
antibiotics. None of the studies reported additional amputation or death as a result of osseointegration.  
Conclusion: Osseointegration of limb amputations confers increased prosthetic use, better sitting 
comfort, improved walking ability, mobility, gait, and quality of life. However, it is associated with an 
increased risk of soft tissue infections. Robust evidence from definitive trial designs are warranted. 
 
Key words: osseointegrated prosthesis, limb amputation, function, quality of life, infection 
 
 
 
  
3 
 
Introduction 
Following an extremity amputation, patients are usually provided with socket-suspended prostheses 
which represent the current standard of care. However, accumulating evidence suggests that these 
traditional sockets can be problematic due to residual volume changes, poor suspension, failure in 
load transfer and stability, and skin problems; thereby reducing the use of the prosthesis and overall 
quality of life.1-5 Over the past two decades, osseointegration has emerged as a novel approach for the 
attachment of an externally fitted prosthesis to an amputated limb. It has been suggested this approach 
addresses many of the socket-related problems associated with socket prosthesis, as it involves direct 
attachment of the prosthesis to the residual bone. The concept of osseointegration emerged over five 
decades ago started by Swedish Professor Per-Ingvar Branemark and its principle is based on the 
ability of living bone cells to attach to metal surfaces.6 After successful experimental studies in rabbit 
models, osseointegration was introduced in humans and employed in dental implants,7 with 
progression to bone-anchored hearing aids and other implants.8 Osseointegration usually involves two 
surgical procedures in which the metal implant is inserted into the bone of the arm or leg and this 
implant penetrates through the skin. The artificial limb or prosthesis is easily attached to this implant 
with a connector (Fig. 1). The technique of osseointegration has been reported to offer many 
advantages compared to socket prostheses and these include improved walking and joint movement, 
longer walking distances, increased stability, ability to quickly put on and off the prosthesis, better 
sitting comfort, and improved image and quality of life.9-16 Though there are potential benefits of 
osseointegration as a result of direct skeletal attachment, the concept of a metal implant protruding 
through the skin and communicating with the external environment has raised substantial concerns 
about the risk of adverse events such as deep infection, osteomyelitis, other complications as well as 
their management.17 The safety and adverse events associated with osseointegration is however 
uncertain because of limited and sparse clinical evidence. In this context, this study aimed to identify 
and summarize any evidence on clinical and functional outcomes as well as adverse effects and 
complications of osseointegration for people with limb amputations using a systematic review as well 
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as qualitative and quantitative synthesis of the literature. The review will cover all observational 
(prospective cohort, nested case-control, or case-control, retrospective cohort) studies, case reports, 
case studies, and interventional studies conducted in patients with upper and lower limb amputations 
who were managed with an osseointegrated implant system. 
 
Methods 
Data sources and search strategy 
This review was conducted in accordance with PRISMA guidelines18(Supplementary Material 1). 
Observational studies (prospective cohort, nested case-control, or case-control, retrospective cohort), 
case studies, case series, qualitative studies, non-randomised studies, and randomised controlled trials 
(RCTs) were searched in MEDLINE, EMBASE, Web of Science, Cochrane Library, and reference 
lists of relevant studies from inception to 23 April 2018. The computer-based searches combined free 
and MeSH search terms and combination of key words related to the intervention (e.g., 
“osseointegration”, “bone regeneration”) and population (e.g., “amputation”, “artificial limbs”). Only 
articles published in English were considered and were restricted to humans. Reference lists of 
relevant articles were manually scanned for additional studies likely to have been missed by the 
electronic search. Details on the MEDLINE search strategy are provided in Supplementary Material 
2.   
 
Study selection 
The following studies were included: those enrolling consecutive patients with upper or lower limb 
amputations who were managed with an osseointegration implant system, had follow-up durations, 
and have reported on clinical and functional outcomes, adverse events or complications associated 
with osseointegration. The intervention was any osseointegrated prosthesis, whether it was a single-
staged or a two-staged procedure. Studies based on osseointegrated finger or digital prostheses were 
not included. The initial screening of titles and abstracts to retrieve potentially relevant articles was 
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performed by one reviewer. Detailed evaluation of the full texts of these relevant articles was 
conducted to determine whether they met all inclusion criteria, and this was conducted independently 
by two reviewers. 
 
Data extraction and quality assessment 
Using a standardized predesigned data collection form, data were extracted on study publication date, 
study design, geographical location, baseline mean or median age, percentage of males, type of 
amputation and indication for amputation, eligibility criteria for implantation, type of implantation, 
duration of follow-up, sample size, and outcomes. Methodological quality of non-randomised studies 
including cohort and case-control studies was assessed based on the nine-point Newcastle–Ottawa 
Scale (NOS).19 It uses three pre-defined domains namely: selection of participants (population 
representativeness), comparability (adjustment for confounders), and ascertainment of outcomes of 
interest. The NOS assigns a maximum of four points for selection, two points for comparability, and 
three points for outcome. Nine points on the NOS reflects the highest study quality. Based on 
previously published evidence,20, 21  we judged studies that received a score of nine points to be at low 
risk of bias, studies that scored seven or eight points to be at medium risk, and those that scored six or 
less to be at high risk of bias.   
 
Outcome measures and definitions 
Outcomes extracted were daily prosthetic use, implant survival rates, adverse events and 
complications as well as measures of function, mobility, satisfaction, and quality of life as assessed by 
validated outcome measures such as 6-minute walk test (6MWT),22 Timed Up & Go (TUG) test,23 K-
levels,24 Short Form-36 (SF-36) scores,25 Questionnaire for Persons with Transfemoral Amputation 
(Q-TFA) scores,26 the Amputation Mobility Predictor (AMPPRO),27 life habits questionnaire (LIFE-
H),28 and the lower extremity scale (LEFS).29 Majority of these outcome measures are based on self-
report questionnaires. The SF-36 is a generic measure for the assessment of general health-related 
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quality of life. The results of this score are presented in eight subscales. The Q-TFA is a condition 
specific outcome measure used for transfemoral amputees and reflects current prosthetic use, 
prosthetic mobility, problems, and global health. Quality of life assessments are conducted using the 
SF-36 and the Q-TFA global score. Walking ability is evaluated using the 6MWT and the TUG test. 
 
Data synthesis and analysis 
Where possible, the proportions or rate of adverse events e.g., infections (estimated from the number 
of patients with adverse events within the period of follow-up/total number of participants) with 95% 
confidence intervals (CIs) were estimated across studies. The Freeman-Tukey variance stabilising 
double arcsine transformation 30 was used in estimating the rates because of the binary nature of the 
data and low rates associated with some of the data. Given the variety of measures reported for the 
outcomes and inconsistent reporting by the studies, a formal meta-analysis could not be performed; a 
narrative synthesis was rather conducted. The findings of such studies were summarised in tables that 
included the main characteristics of the study and the results in natural units as reported by the 
investigators. STATA release 14 (Stata Corp, College Station, Texas, USA) was used for all relevant 
statistical analyses.  
 
Results 
Study identification and selection 
Fig. 2 shows the flow of studies through the review. The initial search of relevant databases and 
manual scanning of reference lists of relevant studies identified 177 potentially relevant citations. 
After the initial screening of which was based on titles and abstracts, 42 articles remained for full text 
evaluation. Following detailed evaluation, 20 articles were excluded because (i) they included 
populations not relevant to review (n=4); (ii) the outcomes reported were not relevant (n=4); (iii) 
populations were based on finger prostheses (n=4); (iv) articles were in German (n=4); however, the 
study patients overlapped with that of another study already included in the review;31 and (v) was a 
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study protocol.  The remaining 22 articles9, 11-16, 31-45 comprising 13 unique studies met the inclusion 
criteria and were included in the review.  
 
Study characteristics and quality 
Table 1 summarises the characteristics of the studies included in the review. Studies were published 
between 2003 and 2017. Studies were conducted in Europe (Sweden, Netherlands, Austria, Germany, 
and the UK) and Australia. Majority of studies were however based on the prospective 
Osseointegrated Prostheses for the Rehabilitation of Amputees (OPRA) study conducted in Sweden. 
A variety of study designs were employed which included observational cohorts (prospective or 
retrospective cohorts), prospective case-control, case series or reports, and qualitative studies. Whiles 
majority of studies were before- and after-designs, two studies compared outcomes in patients using 
osseointegrated prosthesis with those using socket prosthesis.11, 16  One retrospective cohort study split 
patients into two groups to compare outcomes between the first two previous designs and the final 
design of the osseointergrated implant system.44 No RCT was identified. Methodological quality of 
included observational cohort and case-control studies using NOS criteria ranged from 4-8. 
 
Baseline characteristics of study populations 
Sample size of cohorts (excluding case reports or series) ranged from 11 to 100 participants (Table 1). 
Three studies were case series or reports comprising 1-5 patients.33, 40, 41 Though the study populations 
varied and included patients with amputations of the lower and upper limbs, majority of studies were 
conducted in patients with transfemoral amputations (Table 2). Traumatic injury and tumours were 
the major indications for amputation. The mean baseline age of study participants at implantation 
ranged from 42 to 48 years. In a case series of 5 patients with peripheral vascular disease (PVD), age 
at implantation ranged from 56 to 84 years.46 The mean interval between amputation and implantation 
and the mean duration of follow-up after implantation ranged from 9 to 19 years and 1 to 8 years 
respectively. Majority of studies used a two-stage procedure and the implant type used by studies 
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included the Integrated Leg Prosthesis (ILP) or Osseointegration Prosthesis (OIP), Osseointegrated 
Prosthetic Limb (OPL), OPRA, and the Endo-Exo-Femurprosthesis system which is now known as 
the ILP.44 To be considered for an osseointegration prosthesis, common inclusion criteria reported by 
all studies were difficulties or problems with using conventional socket prosthesis, adequate bone 
quality, suitability for surgery based on medical and physical examinations, and motivation to comply 
with treatment and follow-up requirements. Except for the case series comprising of patients with 
PVD,33 all studies considered PVD as an exclusion criterion for osseointegration surgery. 
 
Functional Outcomes 
Walking Ability Seven studies evaluated walking ability using one or two of the following measures: 
6MWT, TUG, LIFE-H, LEFS, and subitems of the Q-TFA Mobility score (Table 3). However, 
majority of these studies used the 6MWT and TUG tests. All studies reported significant improvement 
in this domain at follow-up after having an osseointegrated prosthesis compared with baseline or pre-
operative values when patients were using socket prosthesis or were wheelchair bound. 
 
Prosthetic Use  
Prosthetic use was assessed by the Q-TFA prosthetic use score and this was reported by five studies. 
The prosthetic use score after insertion of an osseointegrated implant improved compared with 
preoperative values. Daily prosthetic use was reported by about 89% of patients at two-year follow-up 
following insertion of an osseointegrated implant.12, 14 In a case series of two patients which aimed to 
determine the effect of the osseointegrated implant together with a customized socket design 
compared with a conventional socket fitting on range of motion of the shoulder  and prosthetic 
function, both patients reported daily prosthesis use at 2-year follow-up.40 However, in a 2-year 
follow-up evaluation of 39 patients with transfemoral osseointergrated prosthesis; increased prosthetic 
use was reported by 26 patients compared with baseline values, whiles 11 patients reported the same 
amount of use at baseline and 2 reported less prosthesis use.13 For studies that explicitly reported on 
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the number of patients still using their osseointegrated prosthesis at the end of follow-up period, 
estimates ranged from 68 to 100% over a mean follow-up period of 1 to 6 years (Table 2). 
 
Mobility  
Six studies evaluated mobility using one or two of the following measures: LIFE-H, LEFS, AMPPRO 
score, K-levels and the Q-TFA subitem prosthetic mobility score (Table 3). All studies reported 
improved mobility of patients during follow-up after osseointegration surgery. In a case series 
involving five patients with transtibial amputation and a history of PVD, of which three patients were 
wheelchair bound at baseline; all five patients were able to walk unaided at 12 months follow-up after 
receiving an osseointegration implant.33 In a qualitative study involving 13 patients with upper or 
lower extremity amputation who had been using osseointegrated prosthesis for 3-5 years, patients 
reported improved function and freedom compared to when they used conventional socket prostheses. 
 
Other Functional Outcomes  
Hagberg and colleagues evaluated hip range of motion and sitting comfort comparing individuals with 
osseintegrated prostheses to those with a socket prosthesis.11 The study results showed that none of 
the individuals with osseintegrated prosthesis reported restriction in hip motion and only one person 
reported discomfort when sitting. Gait patterns preoperatively, with the use of socket prosthesis and 
healthy controls were compared with those at two years following insertion of an osseointegrated 
implant in 19 patients with a unilateral transfemoral amputation; the findings showed that there was a 
significant increase of hip extension and reduction of the pelvic tilt in those with implants and these 
changes approached that of the healthy controls.16 In the case series of two patients, both patients 
reported improved prosthetic function and a decrease in restriction of range of motion using the 
implant with customized sockets compared with conventional socket prosthesis.40 
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Pain 
Except for one study which evaluated pain using the SF-36 Bodily Pain subscore and reported 
significant improvement in this domain at 2-years following osseointegration compared with the 
preoperative situation,12 none of the other studies indicated having evaluated pain using validated 
questionnaires. However, several studies assessed pain as an adverse event or complication after 
osseointegration. In a case series involving five patients with transtibial amputation and a history of 
PVD who received an osseointegration implant, four of the patients were pain-free at one year post-
operative follow-up.33 In the case series of two patients, no pain was reported at the stump on wearing 
prosthesis at 2 years follow-up.40 In a prospective follow-up (approximately 3 months -17.5 years) of 
100 individuals with osseintegrated implants, severe phantom limb pain was reported as the main 
reason why two patients were not using their prostheses.35 In the 2-year follow-up of 51 patients with 
osseointegrated implants by Branemark and colleagues, five patients reported episodic pain during 
rehabilitation and three patients reported pain on weight bearing and this was associated with 
loosening of their implants.14 Two years after treatment with an osseointegrated implant in 39 patients 
with unilateral transfemoral amputation, one patient reported not using the prosthesis at all due to 
loading pain and this was associated with loosening of the implant.13 In the same study, though 
patients showed substantial improvements in prosthetic function and physical quality of life, they 
reported no significant change in phantom limb pain and pain from the back, shoulders, and 
contralateral limb. In the 8 year median follow-up of 16 transhumeral amputees who received 
osseointegrated percutaneous implants, two patients reported pain on loading and three patients had 
phantom pain in their arm.43 In the prospective follow-up of 86 patients with transfemoral amputation 
who were treated with an osseointegration implant, one patient was unable to load the residual limb 
due to severe pain and this led to the removal of the implant.32 
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Quality of Life 
Eight studies assessed general and/or condition-specific health related quality of life using the 
following measures: LIFE-H, LEFS, SF-36 and Q-TFA global score. Studies compared these 
outcomes at follow-up following osseointegration with the preoperative status or when using socket 
prostheses. All studies reported considerable improvement in quality of life at a mean of 2 years 
follow-up (Table 3). In a qualitative study of 13 patients who had been using osseointergrated 
prosthesis for 3-15 years, all patients reported substantial improvement in their functional abilities as 
well as their quality of life.15  However, participants expressed fear of sustaining fractures and 
developing infections which could curtail their improved function and freedom. 
 
Infections 
Fourteen articles reported on infection outcomes. Given that some of the studies were conducted in 
the same study setting, there was a possibility of patient overlap and therefore the pooled infection 
rate was not estimated across the studies. The infection rates with 95% confidence intervals ranged 
from 1.0 (0.2-5.4) to 76.7 (59.1-88.2) over mean follow-up periods of 5 months to 5 years (Fig. 3). 
The majority of infection types were reported as low-grade soft tissue or superficial infections, which 
were treated effectively with oral antibiotics for a few days. A few patients required prolonged 
treatment or parenteral antibiotic therapy. In the study that compared infection outcomes between the 
first two previous designs (Group 1) and the final design (Group 2) of the osseointergrated implant 
system, 77% of patients in Group 1 needed surgical interventions due to infections compared to 
Group 2 patients who remained infection-free.44 Deep infections were reported in two studies - one 
study reported 4 of 51 patients developing deep infection which were successfully treated in 3 patients 
and one had the implant removed due to loosening;14 the other study reported a deep implant infection 
in one patient about 3.5 years after stage 1 osseointegration surgery, but this resolved after 3 months 
of oral antibiotics.43 Two studies reported the development of osteomyelitis in one patient.35, 36 In a 
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long-term follow-up of 96 patients with transfemoral implants (majority who were part of the OPRA 
study), 16 (16.7%) patients developed implant-associated osteomyelitis.45 
 
Other adverse events and complications 
Apart from infection which accounted for majority of adverse events, other adverse events and 
complications reported on follow-up after osseointegration surgery included peri-prosthetic fracture, 
fractures of the implant (abutment), skin reactions, soft-tissue problems, stoma hypergranulation, 
implant failure and removal, loosening of the fixtures, mechanical complications of the abutment, and 
revision surgery (Table 3). Three articles reported one or two patients sustaining fractures of the 
prosthetic components or implant.12, 39, 42 Five articles reported on periprosthetic fractures with rates 
ranging from 3.5 to 44.4%.14, 31, 32, 34, 43 The cumulative survival of the implant reported in two articles 
ranged from 83 to 92% at two years.14, 43 Implant removal rate ranged from 2.6 to 11.0% across six 
articles13, 14, 31, 35-37, 39  and were mainly attributed to infections and loosening. Revision rates ranged 
from 0 to 54.1% across five articles.31, 32, 34, 40, 43  A high complication rate and substantial number of 
adverse events following osseointegration surgery were reported by four articles during follow-up of 
patients. Branemark and colleagues in their 2 year follow-up of 51 patients reported a total of 101 
complications, with 46 patients having one or more complications.14 In 2 to19 years follow-up of 16 
patients with transhumeral osseointegrated implants, a total of 43 adverse events were reported.43 In 
another series of 86 patients who underwent transfemoral osseointegration and were followed for a 
median of 34 months, 26 patients developed one or more complications.32 Infact, only 31 patients 
experienced no complications at all during the follow-up period. In a follow-up of 50 patients with 
transfemoral osseointegrated limbs, 27 patients experienced an adverse event.34 It however appears 
that majority of these adverse events and complications reported in these studies were effectively 
managed using simple strategies. None of the studies reported additional amputation or death as a 
result of the osseointegrated implant. 
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Patient satisfaction 
All studies reported that patients were generally satisfied with the improvement in functional 
outcomes and quality of life after insertion of the osseointegrated implant. Of 37 patients who had an 
Endo-Exo-Femur prosthesis implanted, 35 of them reported that they would choose to have the 
procedure again under similar circumstances.31 However, a number of  studies reported patients’ 
concerns with slowness of rehabilitation after osseointegration surgery and fear of sustaining a 
fracture as a result of a fall or acquiring infections at the skin-implant interface.15, 42 
 
Radiological findings 
Three studies reported on radiological signs of bone remodelling during follow-up after 
osseointegration.32, 37, 43 Common radiological findings reported by these studies included proximal 
trabecular streaming or buttressing, distal and endosteal bone resorption, cancellization, and cortical 
thinning; however, the extent of progression of these changes were inconsistent during the periods of 
follow-up in the studies. Furthermore, in the series of 86 patients who underwent transfemoral 
osseointegration, follow-up radiographs showed stable osseous growth and no implant migration in all 
but one patient, as well as hypertrophic bone formation in the distal part of the femur in 10% of the 
patients.32 
 
Robustness of findings 
Though the reported conclusions from the included studies generally suggest that osseointegrated 
prostheses for both upper and lower limb amputees is associated with improved function, mobility, 
and quality of life (Table 3); the findings should be interpreted with caution given some limitations in 
the study designs used (observational cohorts, case-control studies, and case series/reports), the low 
methodological quality of majority of the studies, lack of appropriate controls in some of the studies, 
self-reports of outcomes by study participants, and selective reporting of outcomes.  
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Discussion 
Using a systematic review approach, this study has assessed evidence on functional outcomes, clinical 
outcomes, as well as adverse effects and complications of osseointegration for patients with 
amputated limbs. All relevant studies reported substantial improvement in walking ability, prosthetic 
use, mobility, satisfaction, or quality of life with an osseointegrated implant compared with their 
preoperative status or when using conventional socket prosthesis. Generally, only few patients 
reported pain as a complication after insertion of an osseointegrated implant and this was usually 
associated with loading or weight bearing. However, in one study, though patients showed significant 
improvements in prosthetic function and physical quality of life after osseointegration, they reported 
no significant change in phantom limb pain and pain from the back, shoulders, and contralateral limb. 
The infection rate ranged from as low as 1.0% to as high as 76.7% across studies, but majority were 
low-grade soft tissue or superficial infections at the skin-implant interface and were effectively treated 
with antibiotics. Two studies reported the development of deep implant infection, the rates which 
were low and majority were successfully treated;14, 43 and one study reported implant-associated 
osteomyelitis in about 16% of patients after a mean of about 8 years following implantation.45 A few 
studies reported a substantial number of adverse events after osseointegration surgery and these 
included peri-prosthetic fractures, skin reactions, soft-tissue problems, stoma hypergranulation, 
implant failure, loosening of the fixtures, mechanical complications of the abutment, and revision 
surgery. Events such as aseptic loosening, implant removal and implant fractures were however low 
in number. Nevertheless, majority of these complications were resolved nonoperatively or using 
simple measures. No study reported further amputation or death as a complication of osseointegration. 
Finally, two studies reported radiological changes after osseointegrative implantation32, 43 which may 
suggest a predisposition to periprosthetic fracture; however, the clinical relevance is not certain given 
the absence of long-term follow-up evidence. 
The consistent findings reported by the included studies suggest that osseointegrative implantation, 
which provides direct skeletal attachment of the prosthesis to the residual limb, indeed offers benefits 
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for both lower and upper limb amputees in the form of increased prosthetic use, improved mobility, 
range of motion, gait, comfort, and quality of life. The current findings are very relevant as it brings 
together the existing evidence and convincingly demonstrates the potential advantages of 
osseointegration for amputees. Socket-mounted prosthesis which have traditionally been the mainstay 
of treatment for patients with lower limb amputations are fraught with problems such as pain, skin 
conditions and ulcerations, heat, sweating, discomfort, failing in load transfer and skeletal control;2, 17, 
47, 48 which reduce the ability to walk and quality of life.3, 9, 49 Over the last two decades, 
osseointegrated implantation has revolutionized the rehabilitation of patients with extremity 
amputations and has obviated problems associated with socket prostheses. Though the advantages of 
osseointegration are numerous, as demonstrated in our review, there are major concerns associated 
with the high risk of infections (up to about 77%) at the skin-implant interface. However, majority of 
these infections are low-grade, soft tissue, or superficial infections which are typically managed 
effectively with oral antibiotics and in some cases, parenteral antibiotics. In addition, with the changes 
in design of the osseointegration implant and surgical techniques over the past decade, it appears 
infection rates associated with this surgery are on the decrease. Indeed, in the recent study which 
compared infection outcomes between two previous versions with a newer version of the implant 
system which was designed to reduce the risk of infection at the skin-implant interface, all patients 
treated with the newer version remained infection free at follow-up.44 Despite the benefits of 
osseointegration, it is not indicated for all amputees. It is usually reserved for patients with 
amputations who cannot tolerate or have problems using the conventional socket prosthesis and 
patients with motivation and emotional stability to comply with rehabilitation, treatment and follow-
up requirements such as stomal wound care; as the whole process following osseointegration is a life-
long and challenging one. Furthermore, amputation due to vascular disease has been regarded as a 
contraindication to osseointegration surgery.9, 14, 32 However, in a case series of five transtibial 
amputees with PVD, osseointegration improved mobility, walking ability, and quality of life in these 
patients as well as reduced the prevalence of pain.33 Given the small number of study participants and 
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short follow-up period, further evidence is required to confirm if osseointegrated implantation will be 
an acceptable treatment for amputees with PVD. Finally, though our review did not evaluate cost 
implications of osseointegration surgery for the patient and the healthcare system because of the 
limited evidence; it appears that the total costs associated with osseointegrated prosthesis are similar 
to that for socket prostheses as demonstrated in a recent cost analysis study.50 Taking the overall 
evidence together, osseointegration may be a suitable and cost-effective  alternative to traditional 
socket prosthesis in some patient populations. Further research is however required on long-term 
complications of osseointegrated surgery, how to prevent or reduce the high risk of infections, and 
identification of populations who will benefit most from this surgery.  
Several strengths and limitations of this review deserve consideration. This study systematically 
examines the clinical outcomes, safety issues, and adverse effects associated with osseointegrated 
implantation in patients with lower and upper limb amputations. The literature search was detailed, 
spanned several databases, and included a diversity of study designs such as observational cohorts, 
case-control studies, qualitative studies, and case series or reports. The review was limited by the 
potential for biases in the study designs employed. However, these study designs were included 
because of the limited evidence on the topic. A meta-analysis of the results could not be performed 
because of the heterogeneous nature of study designs and methods, overlapping participants, and 
inconsistent outcome measures reported by eligible studies. Given the inability to pool the findings, 
analyses taking into consideration the methodological quality of the studies could not be conducted. 
Another limitation was that the protocol for this review could not be registered.  
On the basis of available mixed observational evidence, patients with osseointegration of limb 
amputations have increased prosthetic use, better sitting comfort, improved walking ability, mobility, 
gait, and quality of life. The rates of events such as aseptic loosening, implant removal and implant 
fractures are acceptably low. However, osseointegrative implantation is associated with an increased 
risk of infections, majority of which are low-grade soft tissue infections and respond well to 
antibiotics. Nevertheless, given the limitations associated with some of the study designs and their 
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low methodological quality, these findings need to be interpreted with caution. Robust evidence from 
definitive clinical trials are urgently warranted. Future studies should aim to recruit adequate sample 
sizes, include appropriate controls in their study designs, consistently report validated outcome 
measures, ensure participants are followed up for appropriate durations for the ascertainment of 
outcomes, and not selectively report outcomes. 
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Figure legends 
 
Fig. 1 Osseointegration prosthesis 
 
 
 
A, Radiograph of a transfemoral osseointegration prosthesis; B, Radiograph of a patient with bilateral 
transtibial osseointegration prostheses; C, Patient sitting with a transfemoral osseointegration 
prosthesis 
 
Fig. 2 PRISMA flow diagram 
 
 
 
Fig. 3 Rates of infection across studies 
 
 
CI, confidence interval (bars) 
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Table 1. Summary characteristics of studies included in the review  
Lead author, 
publication 
date 
Location Baseline 
year 
Study design Further details on 
study design 
Population Population 
source (name of 
study) 
Eligibility criteria for 
osseointegration / entry into 
study 
Males (%) Number of 
patients with 
osseointegration 
(no. of implants) 
Drop-out 
rate 
Mean/median 
duration of follow-
up (years) 
Study 
quality 
Sullivan, 2003 UK NR Cohort study Report experiences 
and outcomes of 
patients who have 
completed 
osseointegration 
surgery 
Transfemoral 
amputees 
Healthcare setting Transfemoral amputees unable 
to achieve a satisfactory level 
of rehabilitation using 
conventional socket techniques 
NR 11 NR 5.5 5 
Hagberg, 2005 Sweden and 
UK 
NR Case-control Individuals with 
osseointegrated 
implant compared 
with those with a 
socket prosthesis 
Transfemoral 
amputees 
Healthcare setting 
(OPRA) 
To have a unilateral 
transfemoral amputation, for at 
least 
2 years, for reasons other than 
vascular disease; to be between 
20 and 70 years old; and to be 
a 
prosthetic user, with the ability 
to walk continuously for at 
least 100 m 
75.0 20  NR 5.0 5 
Hagberg, 2008 Sweden 1999-2004 Prospective cohort Prospective follow-
up of individuals 
with osseintegrated 
implants and 
outcomes compared 
with pre-operative 
situation 
Transfemoral 
amputees 
Healthcare setting 
(OPRA) 
Transfemoral amputees with 
problems using a conventional 
socket prosthesis, completed 
maturation of the skeleton as 
well as normal skeletal 
anatomy, age 
below 70 years and to be 
suitable for surgery based upon 
the medical and physical 
examinations. 
 
44.4 18 NR 2.0 5 
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Lead author, 
publication 
date 
Location Baseline 
year 
Study design Further details on 
study design 
Population Population 
source (name of 
study) 
Eligibility criteria for 
osseointegration / entry into 
study 
Males (%) Number of 
patients with 
osseointegration 
(no. of implants) 
Drop-out 
rate 
Mean/median 
duration of follow-
up (years) 
Study 
quality 
Hagberg, 2009 Sweden 1990-2008 Prospective cohort Prospective follow-
up of individuals 
with osseintegrated 
implants and brief 
overview of 
outcomes  
Transfemoral, 
transtibial, 
transulnar, 
transradial, and 
transhumeral 
amputees 
Healthcare setting 
(included 
participants of the 
OPRA study) 
Patients with socket-related 
problems (i.e., discomfort, 
pain, poor suspension,) or 
an inability to use a 
conventional prosthesis at all. 
61.0 100 (106) None 5 5 
Aschoff, 2010 Germany 1999-2009 Prospective cohort Follow-up of patients 
who underwent 
osseointegration 
surgery 
Transfemoral 
(above-knee) 
amputees 
Healthcare setting Persistent difficulties with 
socket prosthesis 
81.1 37 (39) None NR 5 
Tillander, 2010 Sweden 2005 Prospective cohort Prospective follow-
up of individuals 
with osseintegrated 
implants for 
infectious 
complications 
Transfemoral, 
transtibial, 
transulnar, 
transradial, 
transhumeral 
amputees 
Healthcare setting Patients with severe discomfort 
when using conventional 
socket prostheses or poor 
stump conditions 
53.8 39 (45) 4 patients 
lost to 
follow-up 
3.0 5 
Lundberg, 2011 Sweden 1992-2005 Qualitative study Interviews to 
evaluate experience 
of people living with 
an osseointegrated 
prosthesis 
Transfemoral, 
transhumeral, 
transradial amputees 
NR Patients with unilateral upper 
or lower limb amputation, 
having been treated with 
osseointegrated prostheses at 
least three 
years ago; and currently using 
the prosthesis  
53.8 13 NA 3-15 N/A 
Tranberg, 2011 Sweden 1999-2007 Prospective case-
control 
Patients with 
osseointegrated 
implants were 
compared with 
preoperative status, 
with the use of 
socket prosthesis, 
and healthy controls  
Transfemoral 
amputees 
Healthcare setting 
(OPRA) 
Same as OPRA study 47.4 19 NR 2.0 8 
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Lead author, 
publication 
date 
Location Baseline 
year 
Study design Further details on 
study design 
Population Population 
source (name of 
study) 
Eligibility criteria for 
osseointegration / entry into 
study 
Males (%) Number of 
patients with 
osseointegration 
(no. of implants) 
Drop-out 
rate 
Mean/median 
duration of follow-
up (years) 
Study 
quality 
Jonsson, 2011 Sweden 1990-2010 Cohort study Follow-up of 
individuals with 
osseintegrated 
implants 
Thumb, partial hand, 
transradial, and 
transhumeral 
amputees 
Healthcare setting Difficult to fit with a 
conventional prosthesis or 
problems with socket 
prosthesis; adequate bone 
quality assessed by X-ray; no 
contraindicated illness; highly 
motivated patient 
83.8 37 (48) NR 0.3-20.0 5 
Nebergall, 2012 Sweden 1999-2007 Prospective cohort Follow-up of 
individuals with 
osseintegrated 
implants 
Transfemoral Healthcare setting 
(OPRA) 
Same as OPRA study 54.9 51 (55) 1 lost to 
follow-up 
Up to 10 years 5 
Van de Meent, 
2013 
Netherlands 2009-2011 Prospective case-
control 
Compare outcomes 
of patients with 
osseointegrated 
implants with those 
of socket prosthesis 
in the same 
individuals 
Transfemoral 
amputees 
Healthcare setting Patients having problems with 
socket prosthesis 
81.8 22 None 1.0 5 
Branemark, 
2014 
Sweden 1999-2007 Prospective cohort Follow-up of 
individuals with 
osseointegrated 
implants 
Transfemoral 
amputees 
Healthcare setting 
(OPRA) 
Problems with socket 
prosthesis or inability to use it; 
full skeletal maturity; 
suitability for surgery based on 
medical and physical 
examinations, and motivation 
to comply with treatment and 
follow-up requirements 
55.0 51 (55) 3 patients 
withdrawn 
from study 
due to 
reasons 
unrelated 
to implant 
2.0 5 
Hagberg, 2014 Sweden 1999-2007 Prospective case-
control 
Compare outcomes 
of patients with 
osseointegrated 
implants with those 
of socket prosthesis 
in the same 
individuals 
Transfemoral 
amputees 
Healthcare setting 
(OPRA) 
Same as OPRA study 43.6 45 6 patients 
not 
followed 
for 2 years 
2.0 4 
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Lead author, 
publication 
date 
Location Baseline 
year 
Study design Further details on 
study design 
Population Population 
source (name of 
study) 
Eligibility criteria for 
osseointegration / entry into 
study 
Males (%) Number of 
patients with 
osseointegration 
(no. of implants) 
Drop-out 
rate 
Mean/median 
duration of follow-
up (years) 
Study 
quality 
Tsikandylakis, 
2014 
Sweden 1995-2010 Retrospective cohort Follow-up of 
individuals with 
osseointegrated 
implants 
Transhumeral 
amputees 
NR Inability to wear or severe 
problems 
wearing a conventional socket 
prosthesis and compliant 
patients 
88.9 18 NR 8.0 5 
Juhnke, 2015 Germany 1999-2013 Retrospective cohort Patients were divided 
into two groups to 
compare outcomes 
between the first two 
previous designs 
(group 1) and a final 
design (group 2) of 
the osseointergrated 
implant system. 
Transfemoral 
amputees 
Healthcare setting Traumatic amputations and the 
emotional stability and 
intelligence to undergo 
rehabilitation 
Group 1 – 83.0 
Group 2- 80.0 
Group 1 – 30 (31) 
Group 2 – 39 (42) 
NR Group 1 – 6.2 
Group 2 – 2.7 
6 
Schalk, 2015 Netherlands 2010 Case study Case report 
evaluating the level 
of daily life activities 
of a patient before 
and after the 
application of an 
osseointegrated 
implant 
Transfemoral 
amputee 
Healthcare setting Problems with socket 
prosthesis 
NR 1 NA Approximately 3.0 NA 
Salminger, 
2016 
Austria NR Case series Case series to 
determine the effect 
of an osseointegrated 
implant 
Transhumeral 
amputees 
NR Minimal length of the humeral 
bone of 10 cm, sufficient skin 
and soft tissue quality 
especially at the distal third of 
the stump, and healthy 
bone quality in x-ray 
100.0 2 NA 3.0-4.0 N/A 
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Lead author, 
publication 
date 
Location Baseline 
year 
Study design Further details on 
study design 
Population Population 
source (name of 
study) 
Eligibility criteria for 
osseointegration / entry into 
study 
Males (%) Number of 
patients with 
osseointegration 
(no. of implants) 
Drop-out 
rate 
Mean/median 
duration of follow-
up (years) 
Study 
quality 
Muderis, 2016 Australia and 
Netherlands 
2009-2013 Prospective cohort Follow-up of 
individuals with 
osseointegrated 
implants to 
determine safety 
outcomes 
Transfemoral 
amputees 
Healthcare setting Experiencing socket-related 
problems or difficulties using a 
prosthesis 
76.0 86 None 2.8 5 
Muderis, 2016 
(b) 
Australia 2011-2014 Prospective cohort Follow-up of 
individuals with 
osseointegrated 
implants to 
determine outcomes 
Transfemoral 
amputees 
Healthcare setting 
(OGAAP-1) 
Unilateral trans-femoral 
amputation and socket or 
prosthesis-fitting problems 
68.0 50 None 1.8 5 
Muderis, 2017 Australia 2013-2014 Retrospective cohort Retrospective 
analysis of patients 
with osseointegrated 
implants to compare 
outcomes pre-and 
post-operatively 
Transfemoral 
amputees 
Healthcare setting Unilateral trans-femoral 
amputation and socket or 
prosthesis-fitting problems 
77.3 22 NR 1.2 5 
Atallah, 2017 Australia and 
Netherlands 
2014-2015 Case series Case series to 
determine the 
outcomes of patients 
with an 
osseointegrated 
implant 
Transtibial amputees 
with PVD 
Healthcare setting Age over 18 years, unilateral 
transtibial amputation, and a 
history of PVD 
40.0 5 None 1  N/A 
 
N/A, not applicable; NR, not reported; OGAAP-1, Osseointegration Group of Australia’s Accelerated Protocol two-stage strategy (OGAAP-1); OPRA, Osseointegrated Prostheses for the Rehabilitation of Amputees; 
PVD, peripheral vascular disease 
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Table 2. Key characteristics of osseointegration surgery in studies included in review and results of studies reporting patients still using osseointegrated 
prosthesis at end of follow-up 
Lead author, 
publication date 
Population Indications for amputation Mean age at 
amputation 
(years) 
Mean age at 
implantation 
(years) 
Mean interval between 
amputation and 
implantation (years) 
Implant type Surgery type Number of patients with 
osseointegration implants 
Number still using 
the prosthesis at 
end of follow-up 
period 
Sullivan, 2003 Transfemoral amputees NR NR NR NR ITAP Two-stage 11 9 
Hagberg, 2005 Transfemoral amputees Trauma, tumour, and others 27.0 46.0 is age at study 
entry 
19.0 OPRA Two-stage 20  NR 
Hagberg, 2008 Transfemoral amputees Trauma and tumour 31.0 45.0 15.0 OPRA Two-stage 18 17 at 2 years 
Hagberg, 2009 Transfemoral, 
transtibial, transulnar, 
transradial, and 
transhumeral amputees 
Trauma, tumour, and others 32.0 43.0 11.5 OPRA Two-stage 100  68 at a mean of 5 
years follow-up 
Aschoff, 2010 Transfemoral (above-
knee) amputees 
Trauma, tumour, and others 33.0 44.0 NR Endo-Exo-Femurprosthesis Two-stage 37.0 NR 
Tillander, 2010 Transfemoral, 
transtibial, transulnar, 
transradial, 
transhumeral amputees 
Trauma and tumour NR 49.3 is age at study 
entry 
NR OPRA Two-stage 39  NR 
Lundberg, 2011 Transfemoral, 
transhumeral, 
transradial amputees 
Trauma, tumour, and infection 14-45 NR NR OPRA Two-stage 13 NR 
Tranberg, 2011 Transfemoral amputees Trauma, tumour, and infection NR 44.2 15.4 OPRA Two-stage 19 NR 
Jonsson, 2011 Thumb, partial hand, 
transradial, and 
transhumeral amputees 
Trauma, tumour, and 
congenital 
NR 40.9 8.3 NR Two-stage 37 30 
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Lead author, 
publication date 
Population Indications for amputation Mean age at 
amputation 
(years) 
Mean age at 
implantation 
(years) 
Mean interval between 
amputation and 
implantation (years) 
Implant type Surgery type Number of patients with 
osseointegration implants 
Number still using 
the prosthesis at 
end of follow-up 
period 
Nebergall, 2012 Transfemoral Trauma and tumour NR 45.0 NR OPRA Two-stage 51 NR 
Van de Meent, 
2013 
Transfemoral amputees Trauma and tumour NR 46.5 16.4 Integrated Leg Prosthesis or 
Osseointegration Prosthesis 
Two-stage 22 NR 
Branemark, 2014 Transfemoral amputees Trauma and tumour 32.0 44.0 12.0 OPRA Two-stage 51  40 of 45 at 2 years 
Hagberg, 2014 Transfemoral amputees Trauma and tumour 31.0 44.0 NR OPRA Two-stage 45 38 of 39 at 2 years 
Tsikandylakis, 
2014 
Transhumeral amputees Trauma and tumour NR 42.0 9.0 NR Two-stage 18 NR 
Juhnke, 2015 Transfemoral amputees Trauma, tumour, infection, 
burns, and others 
NR Group 1 - 46.0 
Group 2 – 45.0 
NR ILP Two-stage Group 1 – 30  
Group 2 – 39 
NR 
Schalk, 2015 Transfemoral amputees Trauma 21.0 NR NR NR Two-stage 1 NR 
Salminger, 2016 Transhumeral amputees Trauma 23 years and 9 
months prior to 
study 
30 and 50 years 23 years and 9 months Subcutaneous implant-
supported attachment 
One-stage 2 NR 
Muderis, 2016 Transfemoral amputees Trauma and tumour 32.0 48.0 16.0 Osseointegration Prosthesis Two-stage 86 NR 
Muderis, 2016 (b) Transfemoral amputees Trauma, tumour, and others NR 48.4 NR ILP or OPL Two-stage 50 50 at 21.5 months 
Muderis, 2017 Transfemoral amputees Trauma, tumour, and infection NR 46.2 NR OPL One-stage 22 22 at 14 months 
Atallah, 2017 Transtibial amputees 
with PVD 
PVD NR 56-84 4.0-25.0 NR One- or two-stage 5 5 at 1 year 
ILP, Integrated Leg Prosthesis (ILP); ITAP, intraosseous transcutaneous amputation prosthesis; NR, not reported; OIP, Osseointegration Prosthesis; OPL, Osseointegrated Prosthetic Limb; OPRA, Osseointegrated 
Prosthesis for the Rehabilitation of Amputees; PVD, peripheral vascular disease 
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Table 3. Other relevant outcomes reported by eligible studies 
Lead author, 
publication date 
Walking ability Prosthetic use Mobility Quality of life Infections Fractures Implant 
failure/removal or 
revision surgery 
Pain associated with 
implant 
Other outcomes 
Sullivan, 2003 Patients felt they were 
able to walk further and 
do more work wearing 
the osseointegrated 
prosthesis 
NR NR NR 2 of 11 after one year 2 of 11 suffered fractures 
of the abutment 
None NR NR 
Hagberg, 2005 NR NR NR NR NR NR NR NR Participants with an 
osseointegrated implant 
had substantially larger 
hip motion in all 
movements when using 
the prosthesis and 
reported few problems 
with sitting discomfort 
compared to individuals 
with socket prosthesis 
Hagberg, 2008 Evaluated with the Q-
TFA Mobility score 
subscores: 
 
Mean walking-aid 
subscore improved from 
70 to 76 points 
 
Mean walking habit sub-
score improved from 39 
to 57 points 
Evaluated with Q-TFA 
subitem prosthetic use: 
 
Prosthetic use score 
improved by a mean of 
32 score points from 
baseline. 
 
16 of 18 reported daily 
prosthesis use at 2-year 
follow-up; 1 reported 
prosthesis use for 6 days 
a week  
 
Evaluated with Q-TFA 
subitem prosthetic 
mobility: 
 
Improvement in mobility 
score by 17 score points 
from baseline 
Compared general and 
condition-specific health 
related quality of life at 
2-year follow-up with the 
preoperative situation 
using Q-TFA and SF-36: 
 
All four scores of Q-TFA 
and four scales of SF-36 
improved significantly at 
follow-up 
 
2 patients abstained from 
wearing the prosthesis 
for 1-3 days due to 
superficial infection 
1 had broken prosthetic 
components 
NR Evaluated with SF-36 
Bodily Pain subscore: 
 
Significant improvement 
in bodily pain subscore. 
 
1 reported no prosthetic 
use due to pain and 
implant loosening 
NR 
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Lead author, 
publication date 
Walking ability Prosthetic use Mobility Quality of life Infections Fractures Implant 
failure/removal or 
revision surgery 
Pain associated with 
implant 
Other outcomes 
 
Hagberg, 2009 NR NR NR NR 1 patient developed 
osteomyelitis 
NR 11 of 100 patients have 
no implant system at 
follow-up 
 
13 of 100 retreated; 9 
were successful and 4 
unsuccessful 
2 patients not using 
artificial limb because of 
severe phantom limb 
pain 
NR 
Aschoff, 2010 NR NR NR NR 1 intramedullary 
infection 
2 had pertrochanteric 
fracture 
20 of 37 patients had one 
or more revisions 
4 had removal of implant 
1 had implant failure 
NR 14 patients had minor 
revision due to problems 
at stoma 
 
35 of 37 patients stated 
they would have the 
surgery again under 
similar circumstances 
Tillander, 2010 NR NR NR NR 7 of 39 patients at a 
mean of 3 years and were 
mostly of low infectious 
activity: 
2 affected prosthetic use 
and 5 did not; 
2 developed chronic skin 
fistulas 
1 had the implant 
extracted 
1 recovered with 
antibiotics 
NR 1 had implant removed 
due to infection 
NR NR 
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Lead author, 
publication date 
Walking ability Prosthetic use Mobility Quality of life Infections Fractures Implant 
failure/removal or 
revision surgery 
Pain associated with 
implant 
Other outcomes 
1 patient developed acute 
osteomyelitis 
Lundberg, 2011 NR NR Patients reported 
improved function and 
freedom 
NR Patients expressed the 
fear of acquiring 
infections at the skin-
implant interface 
NR NR NR Patients expressed a fear 
of falling that could 
cause fracture 
Tranberg, 2011 NR NR NR NR NR NR NR NR Improvement in walking 
pattern by an increase of 
hip extension and 
reduction of the pelvic 
tilt 
Jonsson, 2011 NR NR NR NR 1 of 37 patients 
developed an infection at 
5 months after the 
surgery 
1 patient experienced a 
fracture of the implant 
after an overload 
accident 
1 had implant removed 
due to infection 
NR 2 patients experienced 
loosening of fixtures 
Nebergall, 2012 NR NR NR NR Reported that 1 implant 
was removed due to 
infection 
NR 4 had implant removed 
due to loosening or 
infection 
NR Cortical thinning, 
cancellization, proximal 
trabecular streaming, and 
distal and endosteal 
resorption 
Van de Meent, 2013 Measured with 6MWT 
and TUG tests: 
 
In 6 minutes participants 
with the implant walked 
significantly further 
(27%) than with the 
socket prosthesis 
 
Evaluated with Q-TFA 
subitem prosthetic use: 
 
Prosthesis use 
significantly improved 
by 45%, from 
56hrs/week with the 
socket prosthesis to 101 
hrs/week with the 
implant 
NR Evaluated with Q-TFA: 
 
Q-TFA global score with 
implant was significantly 
higher (68%) than with a 
socket prosthesis at 1-
year follow-up. 
8 of 22 patients 
developed mild 
infections of the soft 
tissue at the skin-implant 
interface during the 12-
month follow-up period 
NR NR NR NR 
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Lead author, 
publication date 
Walking ability Prosthetic use Mobility Quality of life Infections Fractures Implant 
failure/removal or 
revision surgery 
Pain associated with 
implant 
Other outcomes 
In the TUG test, 
participants with the 
implant were 
significantly 
faster (44%) than with 
the socket prosthesis 
Branemark, 2014 NR Evaluated with Q-TFA 
subitem prosthetic use: 
 
40 of 45 patients (89%) 
reported daily prosthetic 
use at 2-year follow-up.  
 
Mean prosthetic use 
score improved from 47 
preoperatively to 79 at 2 
years postoperatively 
 
Evaluated with Q-TFA 
subitem prosthetic 
mobility: 
 
 
Improvement in mobility 
score by 18 score points 
from baseline to 2 years 
at follow-up 
Evaluated with Q-TFA 
and SF-36: 
 
All four scores of Q-TFA 
and physical function 
scores of SF-36 
improved significantly at 
2-year follow-up 
 
28 of 51 patients 
developed superficial 
infections. There were 41 
infection episodes. 
Majority were treated 
effectively with 
antibiotics. 
4 patients developed 
deep infection. 
4 patients suffered bone 
fractures 
4 patients had implant 
removed because of 
loosening 
 
Cumulative survival at 
two years follow-up was 
92% 
5 patients reported 
episodic pain during 
rehabilitation 
 
3 patients reported pain 
on weight bearing which 
was associated with 
loosening of the implants 
 
A total of 101 
complications were 
reported. 
46 patients reported one 
or more complications. 
 
4 patients had 
mechanical 
complications with the 
abutment but these were 
fixed. 
Hagberg, 2014 Evaluated with Q-TFA 
subitem walking habits: 
 
Improved walking habits 
at follow-up 
 
Evaluated with Q-TFA 
subitem prosthetic use: 
 
Increased prosthetic use 
by 26 of 39 patients; 11 
reported same amount of 
use as baseline; 2 
reported less prosthesis 
use 
Evaluated with Q-TFA 
subitem prosthetic 
mobility: 
 
Improved mobility at 
follow-up 
 
 
Evaluated with Q-TFA 
and SF-36: 
 
All Q-TFA scores 
improved at 2-year 
follow-up except the Q-
TFA walking aid 
subscore. 
 
NR NR 3 patients had implant 
removed due to 
complications 
1 reported no prosthetic 
use due to loading pain 
 
Patients reported no 
significant change in 
phantom limb pain and 
pain from the back, 
shoulders, and 
contralateral limb 
NR 
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Lead author, 
publication date 
Walking ability Prosthetic use Mobility Quality of life Infections Fractures Implant 
failure/removal or 
revision surgery 
Pain associated with 
implant 
Other outcomes 
  
Tsikandylakis, 2014 NR NR NR NR 5 of 16 patients 
developed superficial 
infections of skin 
penetration site at 5-year 
follow-up; 15 episodes of 
infection 
 
1 deep implant infection 
8 patients had incomplete 
distal fracture of the 
residual bone at stage 1 
surgery 
3 patients had implant 
failure. Implant survival 
of 83% and 80% at 2 and 
5 years respectively. 
 
2 patients underwent 
two-stage revision 
surgery 
 
 
2 patients reported pain 
on loading 
 
3 patients had phantom 
pain in their arm 
Total of 43 adverse 
events recorded. 
8 patients developed skin 
reactions at skin 
penetration site; 
3 patients - defective 
bony canal;  
3 patients - avascular 
skin flap necrosis 
Juhnke, 2015 NR NR NR NR Group 1 – 23 out of 30 
patients had surgical 
interventions secondary 
to infection 
Group 2 – No infections 
reported at last follow-up 
NR Group 1 – 4 patients had 
implant removed 
Group 2 – No implants 
removed 
NR 6 out of 30 patients in 
Group 1 and 34 out 39 
patients in Group 2 have 
not had any unplanned 
interventions at all 
Schalk, 2015 Evaluated with LIFE-H 
and LEFS: 
 
Improved walking ability 
NR 
 
Evaluated with LIFE-H 
and LEFS: 
 
Improved mobility 
 
Evaluated with LIFE-H 
and LEFS: 
 
Improved quality of life 
at 3 years follow-up 
 
NR NR NR NR NR 
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Lead author, 
publication date 
Walking ability Prosthetic use Mobility Quality of life Infections Fractures Implant 
failure/removal or 
revision surgery 
Pain associated with 
implant 
Other outcomes 
Salminger, 2016 NR Both patients reported 
daily prosthesis use at 2 
years 
NR NR NR NR Implant survival of 100% 
at 4 years 
 
None had revision 
surgery 
No pain at stump on 
wearing prosthesis at 2-
year follow-up 
Improved prosthetic 
function and decrease in 
restriction of range of 
motion. 
 
 
Al Muderis, 2016 NR NR NR NR 29 of 86 patients 
developed grade 1 or 2 
infections over median 
follow-up of 34 months. 
47 infection episodes 
3 patients sustained 
proximal femoral 
fracture 
2 patients had implant 
replacement due to 
inadequate 
osseointegration and 
severe pain 
1 patient was unable to 
load the residual limb 
because of severe pain 
26 patients developed 
one or more 
complications – e.g. 
stoma hypergranulation, 
soft-tissue redundancy, 
implant breakage etc. 
Al Muderis, 2016 (b) Measured with 6MWT 
and TUG tests: 
 
Significant improvement 
compared with 
preoperative values  
NR 
 
Evaluated with 
AMPPRO scores 
presented as K-levels: 
 
Significant improvement 
compared with 
preoperative values  
Evaluated with Q-TFA 
and SF-36: 
 
Significant improvement 
compared with 
preoperative values at 
21.5 months  
21 of 50 patients 
experienced one or more 
infections 
4 patients sustained 
periprosthetic fractures 
2 patients had revision 
implant 
NR 27 patients experienced 
an adverse event. 
Al Muderis, 2017 Measured with 6MWT 
and TUG tests: 
 
Significant improvement 
compared with 
preoperative values 
NR NR Evaluated with Q-TFA 
and SF-36: 
 
Significant improvement 
compared with 
preoperative values at 12 
months 
12 of 22 patients 
developed minor 
infections at 14 months 
follow-up; there were 15 
infection episodes 
None None None Refashioning surgery 
was performed electively 
in 6 patients. 
No other adverse events 
recorded. 
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Lead author, 
publication date 
Walking ability Prosthetic use Mobility Quality of life Infections Fractures Implant 
failure/removal or 
revision surgery 
Pain associated with 
implant 
Other outcomes 
Atallah, 2017 Measured with 6MWT 
and TUG tests: 
 
Improvement compared 
with baseline 
Evaluated with Q-TFA 
subitem prosthetic use: 
 
Improvement compared 
with baseline 
Evaluated according to 
K-levels: 
 
Mobility levels of all 
patients increased by 1 or 
2 from baseline to 
follow-up 
Evaluated with Q-TFA 
and SF-36: 
 
Improvement compared 
with baseline at 12 
months 
2 of 5 patients had a 
single episode of 
superficial soft-tissue 
infection 
None None 4 of 5 patients were pain 
free at 12 months 
postoperatively 
None reported phantom 
limb sensations. 
 
No reports of implant 
loosening, additional 
amputation, or death 
 
AMPRO, Amputation Mobility Predictor; LEFS, lower extremity scale; LIFE-H, life habits questionnaire; NR, not reported; 6MWT, 6-minute walk test; OPRA, Osseointegrated Prosthesis for 
the Rehabilitation of Amputees; Q-TFA, Questionnaire for Persons with Transfemoral Amputation; SF-36, Short Form-36; TUG, Timed Up & Go 
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Supplementary Material 1. PRISMA checklist 
 
Section/topic 
Item 
No Checklist item 
Reported on 
page No 
Title 
Title 1 Identify the report as a systematic review, meta-analysis, or both Title page 
Abstract 
Structured summary 2 Provide a structured summary including, as applicable, background, objectives, data sources, 
study eligibility criteria, participants, interventions, study appraisal and synthesis methods, 
results, limitations, conclusions and implications of key findings, systematic review registration 
number 
2; Abstract 
Introduction 
Rationale 3 Describe the rationale for the review in the context of what is already known 3-4; Introduction 
Objectives 4 Provide an explicit statement of questions being addressed with reference to participants, 
interventions, comparisons, outcomes, and study design (PICOS) 
3-4; Introduction 
Methods 
Protocol and registration 5 Indicate if a review protocol exists, if and where it can be accessed (such as web address), and, if 
available, provide registration information including registration number 
Not registered 
Eligibility criteria 6 Specify study characteristics (such as PICOS, length of follow-up) and report characteristics (such 
as years considered, language, publication status) used as criteria for eligibility, giving rationale 
4; Study selection 
Information sources 7 Describe all information sources (such as databases with dates of coverage, contact with study 
authors to identify additional studies) in the search and date last searched 
4; Data sources and 
search strategy 
Search 8 Present full electronic search strategy for at least one database, including any limits used, such 
that it could be repeated 
Supplementary 
Material 2 
Study selection 9 State the process for selecting studies (that is, screening, eligibility, included in systematic 
review, and, if applicable, included in the meta-analysis) 
4-5; Study selection 
Data collection process 10 Describe method of data extraction from reports (such as piloted forms, independently, in 
duplicate) and any processes for obtaining and confirming data from investigators 
5; Data extraction 
and quality 
assessment 
Data items 11 List and define all variables for which data were sought (such as PICOS, funding sources) and any 
assumptions and simplifications made 
5; Data extraction 
and quality 
assessment 
Risk of bias in individual 
studies 
12 Describe methods used for assessing risk of bias of individual studies (including specification of 
whether this was done at the study or outcome level), and how this information is to be used in 
any data synthesis 
5; Data extraction 
and quality 
assessment 
Summary measures 13 State the principal summary measures (such as risk ratio, difference in means). Not applicable 
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Section/topic 
Item 
No Checklist item 
Reported on 
page No 
Synthesis of results 14 Describe the methods of handling data and combining results of studies, if done, including 
measures of consistency (such as I2 statistic) for each meta-analysis 
Not applicable 
Risk of bias across studies 15 Specify any assessment of risk of bias that may affect the cumulative evidence (such as 
publication bias, selective reporting within studies) 
Table 1 
Additional analyses 16 Describe methods of additional analyses (such as sensitivity or subgroup analyses, meta-
regression), if done, indicating which were pre-specified 
Not applicable 
Results 
Study selection 17 Give numbers of studies screened, assessed for eligibility, and included in the review, with 
reasons for exclusions at each stage, ideally with a flow diagram 
6 and Fig. 1 
Study characteristics 18 For each study, present characteristics for which data were extracted (such as study size, PICOS, 
follow-up period) and provide the citations 
7 and Table1 
Risk of bias within studies 19 Present data on risk of bias of each study and, if available, any outcome-level assessment (see 
item 12). 
Table 1 
Results of individual 
studies 
20 For all outcomes considered (benefits or harms), present for each study (a) simple summary 
data for each intervention group and (b) effect estimates and confidence intervals, ideally with a 
forest plot 
7-14, Table 2-3  
Synthesis of results 21 Present results of each meta-analysis done, including confidence intervals and measures of 
consistency 
Not applicable 
Risk of bias across studies 22 Present results of any assessment of risk of bias across studies (see item 15) Table 1; Study 
characteristics and 
quality 
 
Additional analysis 23 Give results of additional analyses, if done (such as sensitivity or subgroup analyses, meta-
regression) (see item 16) 
Not applicable 
Discussion 
Summary of evidence 24 Summarise the main findings including the strength of evidence for each main outcome; 
consider their relevance to key groups (such as health care providers, users, and policy makers) 
13-16 
Limitations 25 Discuss limitations at study and outcome level (such as risk of bias), and at review level (such as 
incomplete retrieval of identified research, reporting bias) 
16 
Conclusions 26 Provide a general interpretation of the results in the context of other evidence, and implications 
for future research 
16 
Funding 
Funding 27 Describe sources of funding for the systematic review and other support (such as supply of data) 
and role of funders for the systematic review 
17 
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Supplementary Material 2. Literature search strategy 
 
Relevant studies, published before 23 April 2018 (date last searched), were identified through electronic searches limited 
to the English language using MEDLINE, EMBASE, Web of Science, and Cochrane Library. Electronic searches were 
supplemented by scanning reference lists of articles identified for all relevant studies (including review articles) and by 
hand searching of relevant journals. The computer-based searches combined search terms related to osseointegration and 
amputation. 
 
1     exp Osseointegration/ (9065) 
2     exp Amputation/ (20451) 
3     exp Amputees/ (3196) 
4     exp Artificial Limbs/ (6598) 
5     2 or 3 or 4 (26008) 
6     1 and 5 (97) 
7     limit 6 to (english language and humans) (74) 
 
*************************** 
 
Each part was specifically translated for searching the other databases (EMBASE, Web of Science, and Cochrane databases) 
 
 
 
 
 
 
 
